Cargando…
The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese
BACKGROUND/OBJECTIVE: Apolipoprotein A5 gene promoter region T-1131C polymorphism (APOA5 T-1131C) is known to be associated with elevated plasma TG levels, although little is known of the influence of the interaction between APOA5 T-1131C and lifestyle modification on TG levels. To investigate this...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Nutrition Society and the Korean Society of Community Nutrition
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523481/ https://www.ncbi.nlm.nih.gov/pubmed/26244076 http://dx.doi.org/10.4162/nrp.2015.9.4.379 |
_version_ | 1782384069912297472 |
---|---|
author | Yamasaki, Masayuki Mutombo, Paulin Beya wa Bitadi Iwamoto, Mamiko Nogi, Akiko Hashimoto, Michio Nabika, Toru Shiwaku, Kuninori |
author_facet | Yamasaki, Masayuki Mutombo, Paulin Beya wa Bitadi Iwamoto, Mamiko Nogi, Akiko Hashimoto, Michio Nabika, Toru Shiwaku, Kuninori |
author_sort | Yamasaki, Masayuki |
collection | PubMed |
description | BACKGROUND/OBJECTIVE: Apolipoprotein A5 gene promoter region T-1131C polymorphism (APOA5 T-1131C) is known to be associated with elevated plasma TG levels, although little is known of the influence of the interaction between APOA5 T-1131C and lifestyle modification on TG levels. To investigate this matter, we studied APOA5 T-1131C and plasma TG levels of subjects participating in a three-month lifestyle modification program. SUBJECTS/METHODS: A three-month lifestyle modification program was conducted with 297 participants (Age: 57 ± 8 years) in Izumo City, Japan, from 2001-2007. Changes in energy balance (the difference between energy intake and energy expenditure) and BMI were used to evaluate the participants' responses to the lifestyle modification. RESULTS: Even after adjusting for confounding factors, plasma TG levels were significantly different at baseline among three genotype subgroups: TT, 126 ± 68 mg/dl; TC, 134 ± 74 mg/dl; and CC, 172 ± 101 mg/dl. Lifestyle modification resulted in significant reductions in plasma TG levels in the TT, TC, and CC genotype subgroups: -21.9 ± 61.0 mg/dl, -20.9 ± 51.0 mg/dl, and -42.6 ± 78.5 mg/dl, respectively, with no significant differences between them. In a stepwise regression analysis, age, APOA5 T-1131C, body mass index (BMI), homeostasis model assessment-insulin resistance (HOMA-IR), and the 18:1/18:0 ratio showed independent association with plasma TG levels at baseline. In a general linear model analysis, APOA5 T-1131C C-allele carriers showed significantly greater TG reduction with decreased energy balance than wild type carriers after adjustment for age, gender, and baseline plasma TG levels. CONCLUSIONS: The genetic effects of APOA5 T-1131C independently affected plasma TG levels. However, lifestyle modification was effective in significantly reducing plasma TG levels despite the APOA5 T-1131C genotype background. |
format | Online Article Text |
id | pubmed-4523481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | The Korean Nutrition Society and the Korean Society of Community Nutrition |
record_format | MEDLINE/PubMed |
spelling | pubmed-45234812015-08-04 The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese Yamasaki, Masayuki Mutombo, Paulin Beya wa Bitadi Iwamoto, Mamiko Nogi, Akiko Hashimoto, Michio Nabika, Toru Shiwaku, Kuninori Nutr Res Pract Original Research BACKGROUND/OBJECTIVE: Apolipoprotein A5 gene promoter region T-1131C polymorphism (APOA5 T-1131C) is known to be associated with elevated plasma TG levels, although little is known of the influence of the interaction between APOA5 T-1131C and lifestyle modification on TG levels. To investigate this matter, we studied APOA5 T-1131C and plasma TG levels of subjects participating in a three-month lifestyle modification program. SUBJECTS/METHODS: A three-month lifestyle modification program was conducted with 297 participants (Age: 57 ± 8 years) in Izumo City, Japan, from 2001-2007. Changes in energy balance (the difference between energy intake and energy expenditure) and BMI were used to evaluate the participants' responses to the lifestyle modification. RESULTS: Even after adjusting for confounding factors, plasma TG levels were significantly different at baseline among three genotype subgroups: TT, 126 ± 68 mg/dl; TC, 134 ± 74 mg/dl; and CC, 172 ± 101 mg/dl. Lifestyle modification resulted in significant reductions in plasma TG levels in the TT, TC, and CC genotype subgroups: -21.9 ± 61.0 mg/dl, -20.9 ± 51.0 mg/dl, and -42.6 ± 78.5 mg/dl, respectively, with no significant differences between them. In a stepwise regression analysis, age, APOA5 T-1131C, body mass index (BMI), homeostasis model assessment-insulin resistance (HOMA-IR), and the 18:1/18:0 ratio showed independent association with plasma TG levels at baseline. In a general linear model analysis, APOA5 T-1131C C-allele carriers showed significantly greater TG reduction with decreased energy balance than wild type carriers after adjustment for age, gender, and baseline plasma TG levels. CONCLUSIONS: The genetic effects of APOA5 T-1131C independently affected plasma TG levels. However, lifestyle modification was effective in significantly reducing plasma TG levels despite the APOA5 T-1131C genotype background. The Korean Nutrition Society and the Korean Society of Community Nutrition 2015-08 2015-06-19 /pmc/articles/PMC4523481/ /pubmed/26244076 http://dx.doi.org/10.4162/nrp.2015.9.4.379 Text en ©2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Yamasaki, Masayuki Mutombo, Paulin Beya wa Bitadi Iwamoto, Mamiko Nogi, Akiko Hashimoto, Michio Nabika, Toru Shiwaku, Kuninori The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese |
title | The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese |
title_full | The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese |
title_fullStr | The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese |
title_full_unstemmed | The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese |
title_short | The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese |
title_sort | interaction of apolipoprotein a5 gene promoter region t-1131c polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in japanese |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523481/ https://www.ncbi.nlm.nih.gov/pubmed/26244076 http://dx.doi.org/10.4162/nrp.2015.9.4.379 |
work_keys_str_mv | AT yamasakimasayuki theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT mutombopaulinbeyawabitadi theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT iwamotomamiko theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT nogiakiko theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT hashimotomichio theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT nabikatoru theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT shiwakukuninori theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT yamasakimasayuki interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT mutombopaulinbeyawabitadi interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT iwamotomamiko interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT nogiakiko interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT hashimotomichio interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT nabikatoru interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese AT shiwakukuninori interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese |